Revenue | ₹167.17Cr |
Net Profits | ₹32.38Cr |
Net Profit Margins | 19.37% |
Senores Pharmaceuticals Ltd’s revenue jumped 63.11% since last year same period to ₹167.17Cr in the Q2 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 18.27% jump in its revenue since last 3-months.
Senores Pharmaceuticals Ltd’s net profit jumped 152.18% since last year same period to ₹32.38Cr in the Q2 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 64.12% jump in its net profits since last 3-months.
Senores Pharmaceuticals Ltd’s net profit margin jumped 54.61% since last year same period to 19.37% in the Q2 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 38.77% jumped in its net profit margins since last 3-months.
The revenue for Senores Pharmaceuticals Ltd in the Q2 results 2025 was ₹167.17Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q2 results 2025 was ₹32.38Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q2 results 2025 was 19.37%.
The revenue for Senores Pharmaceuticals Ltd in the Q2 results 2024 was ₹102.49Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q2 results 2024 was ₹12.84Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q2 results 2024 was 12.53%.